Valproic Acid
Back to searchMolecule Structure
Scientific Name
Valproic Acid
Description of the Drug
Valproic acid is an anticonvulsant used to control complex partial seizures and both simple and complex absence seizures.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00313
http://www.drugbank.ca/drugs/DB00313
Brand Name(s)
Convulex, Depakene, Depakote, Stavzor, Valproic acid
Company Owner(s)
Eywa Pharma Inc, Abbott Laboratories Pharmaceutical Products Div, Rp Scherer North America Div Rp Scherer Corp, Abbvie Inc, Mylan Pharmaceuticals Inc, Impax Laboratories Inc, Zydus Pharmaceuticals Usa Inc, Prinston Pharmaceutical Inc, Bionpharma Inc, Cosette Pharmaceuticals Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Succinate semialdehyde dehydrogenase | SINGLE PROTEIN | INHIBITOR | CHEMBL1911 |
Clinical Trial(s)
Unichem Links
| Atlas | valproic acid | |||||||
| SureChEMBL | SCHEMBL2275 | |||||||
| PharmGKB | PA451846 | |||||||
| Human Metabolome Database | HMDB0001877 | |||||||
| DrugBank | DB00313 | |||||||
| PubChem: Thomson Pharma | 15321539 | |||||||
| PubChem | 3121 | |||||||
| Mcule | MCULE-7136317196 | |||||||
| NMRShiftDB | 20200678 | |||||||
| LINCS | LSM-4620 | |||||||
| Nikkaji | J4.972G | |||||||
| PDBe | 2PP | |||||||
| BindingDB | 50003616 | |||||||
| EPA CompTox Dashboard | DTXSID6023733 | |||||||
| LipidMaps | LMFA01020291 | |||||||
| DrugCentral | 2803 | |||||||
| Brenda | 2424 | 104648 | 107471 | |||||
| ChemicalBook | CB7149528 | |||||||
| Guide to Pharmacology | 7009 | |||||||
| rxnorm | DEPACON | VALPROATE | DEPAKOTE | MAGNESIUM VALPROATE | DIVALPROEX SODIUM | DEPAKENE | SODIUM VALPROATE | VALPROIC ACID |
| PubChem: Drugs of the Future | 12015354 | |||||||
| KEGG Ligand | C07185 | |||||||
| ChEBI | 39867 | |||||||
| ZINC | ZINC000003008621 |
